Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

femseven

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
A brief review of women reporting seizures
  • P. Briggs
  • Post reproductive health
  • 2019
    • Corpus ID: 210181386
Fluctuating hormone levels and seizures – the possible impact of the menopause transition on new and established diagnoses of… Expand
2016
2016
A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol
Background Luteinising hormone-releasing hormone agonists (LHRHa), used as androgen deprivation therapy (ADT) in prostate cancer… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
2015
2015
Erythema nodosum as a result of estrogen patch therapy for prostate cancer: a case report
IntroductionErythema nodosum is often associated with a distressing symptomatology, including painful subcutaneous nodules… Expand
  • figure 1
2014
2014
Prostate Adenocarcinoma: TransCutaneous Hormones, PR09 (PATCH): A randomized controlled trial of transdermal estrogen patches versus luteinising hormone releasing hormone agonists in locally advanced…
TPS5099 Background: Contemporary androgen deprivation therapy (ADT) with luteinising hormone releasing hormone agonists (LHRH… Expand
Highly Cited
2005
Highly Cited
2005
Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study
The potential role of estrogen in protecting women from cognitive decline and reducing depressive symptoms is of great… Expand
1999
1999
Impact of Transdermal Estrogens Treatment on Postmenopausal Symptoms and Health-related Quality of Life: an Italian Multicentre Trial: P-90.
Summary Objective To compare efficacy, tolerability and health-related quality of li- fe (HRQoL) of two transdermal therapy… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE